Nu Skin Enterprises Stock Price, News & Analysis (NYSE:NUS) $17.61 +0.05 (+0.28%) (As of 12/4/2023 ET) Add Compare Share Share Today's Range$17.43▼$18.0450-Day Range$16.33▼$21.5652-Week Range$16.15▼$45.55Volume441,070 shsAverage Volume587,593 shsMarket Capitalization$870.11 millionP/E Ratio14.92Dividend Yield8.86%Price Target$29.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Nu Skin Enterprises MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside67.5% Upside$29.50 Price TargetShort InterestHealthy4.09% of Float Sold ShortDividend StrengthStrongBased on Four FactorsSustainability-2.56Upright™ Environmental ScoreNews Sentiment-0.14Based on 2 Articles This WeekInsider TradingSelling Shares$390,992 Sold Last QuarterProj. Earnings Growth35.43%From $1.75 to $2.37 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.3.17 out of 5 starsConsumer Staples Sector3rd out of 134 stocksDrugs, Proprietaries, & Sundries Industry1st out of 7 stocks 3.0 Analyst's Opinion Consensus RatingNu Skin Enterprises has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 4 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $29.50, Nu Skin Enterprises has a forecasted upside of 67.5% from its current price of $17.61.Amount of Analyst CoverageNu Skin Enterprises has only been the subject of 2 research reports in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted4.09% of the float of Nu Skin Enterprises has been sold short.Short Interest Ratio / Days to CoverNu Skin Enterprises has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Nu Skin Enterprises has recently decreased by 13.48%, indicating that investor sentiment is improving significantly. Previous Next 4.2 Dividend Strength Dividend LeadershipNu Skin Enterprises is a leading dividend payer. It pays a dividend yield of 8.88%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthNu Skin Enterprises has been increasing its dividend for 23 years.Dividend CoverageThe dividend payout ratio of Nu Skin Enterprises is 132.20%. Payout ratios above 75% are not desirable because they may not be sustainable.Dividend SustainabilityBased on earnings estimates, Nu Skin Enterprises will have a dividend payout ratio of 65.82% next year. This indicates that Nu Skin Enterprises will be able to sustain or increase its dividend. Previous Next 1.4 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreNu Skin Enterprises has received a -31.22% net impact score from Upright. The largest negative impact of Nu Skin Enterprises in category "GHG emissions" is driven by its "Skin exfoliants" product. See details.Environmental SustainabilityThe Environmental Impact score for Nu Skin Enterprises is -2.56. Previous Next 2.1 News and Social Media Coverage News SentimentNu Skin Enterprises has a news sentiment score of -0.14. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.59 average news sentiment score of Consumer Staples companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Nu Skin Enterprises this week, compared to 2 articles on an average week.Search Interest7 people have searched for NUS on MarketBeat in the last 30 days. This is an increase of 40% compared to the previous 30 days.MarketBeat Follows4 people have added Nu Skin Enterprises to their MarketBeat watchlist in the last 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Nu Skin Enterprises insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $390,992.00 in company stock.Percentage Held by InsidersOnly 2.80% of the stock of Nu Skin Enterprises is held by insiders.Percentage Held by Institutions73.62% of the stock of Nu Skin Enterprises is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 3.8 Earnings and Valuation Earnings GrowthEarnings for Nu Skin Enterprises are expected to grow by 35.43% in the coming year, from $1.75 to $2.37 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Nu Skin Enterprises is 14.92, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 114.82.Price to Earnings Ratio vs. SectorThe P/E ratio of Nu Skin Enterprises is 14.92, which means that it is trading at a less expensive P/E ratio than the Consumer Staples sector average P/E ratio of about 18.36.Price to Book Value per Share RatioNu Skin Enterprises has a P/B Ratio of 0.97. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Nu Skin Enterprises Stock (NYSE:NUS)Nu Skin Enterprises, Inc., together with its subsidiaries, develops and distributes various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO, ageLOC Body Spa; and nutricentials skin care products. The company also provides wellness products, such as ageLOC Meta, LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.Read More NUS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NUS Stock News HeadlinesNovember 29, 2023 | finance.yahoo.comNu Skin Opens New Manufacturing Facility in ChinaNovember 17, 2023 | finance.yahoo.comHere's Why We're Wary Of Buying Nu Skin Enterprises' (NYSE:NUS) For Its Upcoming DividendDecember 4, 2023 | DTI Trader (Ad)New CBOE “special perk” helps traders target income every weekendYou might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange. November 7, 2023 | finance.yahoo.comInsider Sell: Director Andrew Lipman Sells 15,400 Shares of Nu Skin Enterprises IncNovember 5, 2023 | finance.yahoo.comNu Skin Enterprises (NYSE:NUS) Is Paying Out A Dividend Of $0.39November 2, 2023 | finance.yahoo.comNu Skin Enterprises, Inc. (NYSE:NUS) Q3 2023 Earnings Call TranscriptNovember 2, 2023 | seekingalpha.comNu Skin Enterprises, Inc. 2023 Q3 - Results - Earnings Call PresentationNovember 1, 2023 | finance.yahoo.comNu Skin Enterprises Inc (NUS) Reports Q3 2023 Financial ResultsDecember 4, 2023 | DTI Trader (Ad)New CBOE “special perk” helps traders target income every weekendYou might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange. November 1, 2023 | finance.yahoo.comNu Skin Enterprises Reports Third Quarter 2023 Financial ResultsOctober 17, 2023 | seekingalpha.comNu Skin: Is It Just A Growth Problem?October 3, 2023 | finance.yahoo.comNu Skin Enterprises to Announce Third Quarter 2023 Financial ResultsSeptember 29, 2023 | markets.businessinsider.comHold Rating on Nu Skin Amid Market Underperformance and Worsening Trends: An Analysis of Chasen Bender’s Revised ProjectionsSeptember 26, 2023 | finance.yahoo.comIs Nu Skin Enterprises (NUS) Too Good to Be True? A Comprehensive Analysis of a Potential Value TrapSeptember 21, 2023 | msn.comNu Skin (NUS) Down More Than 25% in 3 Months: Here's WhySeptember 13, 2023 | insidermonkey.com5 Worst Performing Dividend Stocks YTDSeptember 2, 2023 | finance.yahoo.comThe Returns On Capital At Nu Skin Enterprises (NYSE:NUS) Don't Inspire ConfidenceAugust 31, 2023 | finance.yahoo.comNu Skin (NUS) Down 11.5% Since Last Earnings Report: Can It Rebound?August 29, 2023 | finance.yahoo.comNu Skin (NUS) Down More Than 30% in 3 Months: Here's WhyAugust 29, 2023 | finance.yahoo.comNu Skin Ranked the World’s #1 Brand for Beauty Device Systems for Six Consecutive YearsAugust 19, 2023 | finance.yahoo.comNu Skin Enterprises, Inc. (NYSE:NUS) is largely controlled by institutional shareholders who own 75% of the companyAugust 5, 2023 | finance.yahoo.comNu Skin Enterprises (NYSE:NUS) Has Affirmed Its Dividend Of $0.39August 3, 2023 | msn.comStifel Maintains Nu Skin Enterprises, Inc. - (NUS) Hold RecommendationAugust 2, 2023 | finance.yahoo.comNu Skin (NUS) Lowers 2023 Guidance Despite Q2 Earnings BeatAugust 2, 2023 | finance.yahoo.comQ2 2023 NU Skin Enterprises Inc Earnings CallAugust 1, 2023 | finance.yahoo.comNu Skin Enterprises Reports Second Quarter 2023 Financial ResultsJuly 27, 2023 | finance.yahoo.com12 Best Dividend Stocks Under $30See More Headlines Receive NUS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nu Skin Enterprises and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 9/6 Dividend8/24/2023Dividend Payable9/06/2023Last Earnings11/01/2023Ex-Dividend for 12/6 Dividend11/22/2023Today12/04/2023Dividend Payable12/06/2023Fiscal Year End12/31/2023Next Earnings (Estimated)2/21/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Drugs, proprietaries, & sundries Sub-IndustryPersonal Products SectorConsumer Staples Current SymbolNYSE:NUS CUSIP67018T10 CIK1021561 Webwww.nuskinenterprises.com Phone(801) 345-1000Fax801-345-5999Employees3,800Year FoundedN/APrice Target and Rating Average Stock Price Target$29.50 High Stock Price Target$39.00 Low Stock Price Target$23.00 Potential Upside/Downside+67.4%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)$1.18 Trailing P/E Ratio14.93 Forward P/E Ratio10.07 P/E GrowthN/ANet Income$104.78 million Net Margins2.92% Pretax Margin2.08% Return on Equity13.44% Return on Assets6.43% Debt Debt-to-Equity Ratio0.44 Current Ratio1.62 Quick Ratio0.94 Sales & Book Value Annual Sales$2.23 billion Price / Sales0.39 Cash Flow$4.44 per share Price / Cash Flow3.97 Book Value$18.13 per share Price / Book0.97Miscellaneous Outstanding Shares49,410,000Free Float48,026,000Market Cap$870.60 million OptionableOptionable Beta1.12 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for December 2023. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Steven J. Lund (Age 70)Executive Chairman of the Board Comp: $659.21kMr. Ryan S. Napierski (Age 49)President, CEO & Director Comp: $1.28MDr. Joseph Y. Chang Ph.D. (Age 70)Executive VP & Chief Scientific Officer Comp: $907.04kMr. Chayce David Clark (Age 40)Executive VP & General Counsel Comp: $593.66kMs. Mang Yee Tang (Age 52)Strategic Advisor Comp: $769.56kMr. Blake M. Roney (Age 64)Founder Comp: $621.69kMs. Sandra N. Tillotson (Age 66)Founder Comp: $1.06MMr. James D. Thomas (Age 44)Executive VP, Chief Accounting Officer & CFO Mr. Joe SueperSenior VP & CTOMr. Mark L. Adams (Age 71)Chief Information Officer More ExecutivesKey CompetitorsMaison SolutionsNASDAQ:MSSCentral Garden & PetNASDAQ:CENTJ&J Snack FoodsNASDAQ:JJSFBruush Oral CareNASDAQ:BRSHWYanGuFang International GroupNASDAQ:YGFView All CompetitorsInsiders & InstitutionsAmerican Century Companies Inc.Sold 104,614 shares on 11/30/2023Ownership: 0.772%Andrew D LipmanSold 2,000 sharesTotal: $34,220.00 ($17.11/share)Deutsche Bank AGBought 3,021 shares on 11/24/2023Ownership: 0.047%EP Wealth Advisors LLCSold 64,509 shares on 11/24/2023Ownership: 0.021%Public Sector Pension Investment BoardSold 26,834 shares on 11/22/2023Ownership: 0.125%View All Insider TransactionsView All Institutional Transactions NUS Stock Analysis - Frequently Asked Questions Should I buy or sell Nu Skin Enterprises stock right now? 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Nu Skin Enterprises in the last year. There are currently 4 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" NUS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NUS, but not buy additional shares or sell existing shares. View NUS analyst ratings or view top-rated stocks. What is Nu Skin Enterprises' stock price target for 2024? 4 brokerages have issued 1 year target prices for Nu Skin Enterprises' shares. Their NUS share price targets range from $23.00 to $39.00. On average, they anticipate the company's stock price to reach $29.50 in the next year. This suggests a possible upside of 67.5% from the stock's current price. View analysts price targets for NUS or view top-rated stocks among Wall Street analysts. How have NUS shares performed in 2023? Nu Skin Enterprises' stock was trading at $42.16 at the beginning of the year. Since then, NUS shares have decreased by 58.2% and is now trading at $17.61. View the best growth stocks for 2023 here. Are investors shorting Nu Skin Enterprises? Nu Skin Enterprises saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 2,300,000 shares, an increase of 28.5% from the October 15th total of 1,790,000 shares. Based on an average daily trading volume, of 571,300 shares, the days-to-cover ratio is currently 4.0 days. Currently, 4.7% of the shares of the company are short sold. View Nu Skin Enterprises' Short Interest. When is Nu Skin Enterprises' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 21st 2024. View our NUS earnings forecast. How were Nu Skin Enterprises' earnings last quarter? Nu Skin Enterprises, Inc. (NYSE:NUS) announced its earnings results on Wednesday, November, 1st. The company reported $0.56 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.64 by $0.08. The company earned $498.80 million during the quarter, compared to the consensus estimate of $520.09 million. Nu Skin Enterprises had a net margin of 2.92% and a trailing twelve-month return on equity of 13.44%. The company's quarterly revenue was down 7.3% on a year-over-year basis. During the same period last year, the business posted $0.47 EPS. How often does Nu Skin Enterprises pay dividends? What is the dividend yield for Nu Skin Enterprises? Nu Skin Enterprises announced a quarterly dividend on Wednesday, November 1st. Investors of record on Friday, November 24th will be paid a dividend of $0.39 per share on Wednesday, December 6th. This represents a $1.56 dividend on an annualized basis and a dividend yield of 8.86%. The ex-dividend date of this dividend is Wednesday, November 22nd. Read our dividend analysis for NUS. Is Nu Skin Enterprises a good dividend stock? Nu Skin Enterprises (NYSE:NUS) pays an annual dividend of $1.56 per share and currently has a dividend yield of 8.88%. NUS has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The company has been increasing its dividend for 23 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 132.20%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, NUS will have a dividend payout ratio of 65.82% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for NUS. What ETFs hold Nu Skin Enterprises' stock? ETFs with the largest weight of Nu Skin Enterprises (NYSE:NUS) stock in their portfolio include Invesco S&P SmallCap Consumer Staples ETF (PSCC), Invesco High Yield Equity Dividend Achievers ETF (PEY), Invesco S&P SmallCap High Dividend Low Volatility ETF (XSHD), Global X Health & Wellness ETF (BFIT), AdvisorShares Dorsey Wright Short ETF (DWSH), What guidance has Nu Skin Enterprises issued on next quarter's earnings? Nu Skin Enterprises updated its FY23 earnings guidance on Wednesday, November, 1st. The company provided earnings per share guidance of $1.62-1.77 for the period, compared to the consensus EPS estimate of $2.36. The company issued revenue guidance of $1.92-1.96 billion, compared to the consensus revenue estimate of $2.05 billion. What is Ritch Wood's approval rating as Nu Skin Enterprises' CEO? 72 employees have rated Nu Skin Enterprises Chief Executive Officer Ritch Wood on Glassdoor.com. Ritch Wood has an approval rating of 91% among the company's employees. This puts Ritch Wood in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Nu Skin Enterprises own? Based on aggregate information from My MarketBeat watchlists, some companies that other Nu Skin Enterprises investors own include Alibaba Group (BABA), General Electric (GE), NVIDIA (NVDA), Marathon Petroleum (MPC), Gilead Sciences (GILD), Alphabet (GOOG), Tesla (TSLA), Herbalife (HLF), Mastercard (MA) and Netflix (NFLX). Who are Nu Skin Enterprises' major shareholders? Nu Skin Enterprises' stock is owned by many different institutional and retail investors. Top institutional shareholders include Invesco Ltd. (3.43%), Morgan Stanley (2.23%), Charles Schwab Investment Management Inc. (1.97%), Bank of New York Mellon Corp (1.54%), Northern Trust Corp (1.12%) and Victory Capital Management Inc. (0.92%). Insiders that own company stock include Andrew D Lipman, D Matthew Dorny, Edwina D Woodbury, Emma S Battle, James D Thomas, Jeffrey Clark Bettinger, Joseph Y Chang, Laura Nathanson, Mark H Lawrence, Ritch N Wood, Ryan S Napierski, Steven Keith Hatchett and Steven Lund. View institutional ownership trends. How do I buy shares of Nu Skin Enterprises? Shares of NUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (NYSE:NUS) was last updated on 12/4/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nu Skin Enterprises, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.